Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs remifentanil for analgesia and respiratory parameters in stereotactic brain biopsy
IRCT20210415050983N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and remifentanil in brain lesion (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Analgesia quality and Respiratory parameters. Started Dec 2021; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
brain lesion
Beyond the preview
Go deeper on IRCT20210415050983N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050983N2.